Archive · 2 Jun 2025
Liquid Biopsy Rollout: Revolutionizing Cancer Diagnosis and Treatment
Imagine a blood test that can find cancer much faster than before!
That's the idea behind the liquid biopsy.
It looks for tiny pieces of cancer DNA in your blood to help doctors choose the best treatments quickly.
This new test is being used in England to help people with lung and breast cancer.
It can help them get the right medicine sooner, sometimes even avoiding extra tests or treatments.
This also helps the NHS save money, making cancer care better and faster for many people.
The NHS is rolling out liquid biopsies to fast-track cancer diagnosis and treatment.
The test detects ctDNA in blood to identify genetic mutations and guide targeted therapies.
It benefits up to 15,000 lung cancer and 5,000 advanced breast cancer patients annually.
Liquid biopsies can provide results up to 16 days faster than traditional tissue biopsies.
The NHS anticipates savings of up to £11 million annually in lung cancer care.
- Who
- Patients with suspected lung and advanced breast cancer
- What
- Liquid biopsy, a blood test for faster cancer diagnosis and treatment.
- When
- The test is now being rolled out.
- Where
- England
- Why
- To provide faster and more effective treatments, potentially avoiding unnecessary procedures.
- How it Works
- Detects ctDNA fragments in blood to identify genetic mutations.
- Patients Benefiting
- 15,000 lung cancer patients and 5,000 advanced breast cancer patients annually.
- Location of Rollout
- England
- Speed Improvement
- Up to 16 days faster than tissue biopsies for lung cancer.
- Potential NHS Savings
- Up to £11 million annually in lung cancer care.
- Implementation Lead
- The NHS Genomic Medicine Service.